DWAS

Invesco Dorsey Wright SmallCap Momentum ETF

Small / Mid CapNASDAQ-GMInvesco ETF
$119.46
$1.56 (+1.33%)
Delayed ≥20 min · Aug 13, 2026

Key Statistics

Net Assets (AUM)
$455.15M
Expense Ratio
See prospectus
Previous Close
$117.90
Day Range
$117.13 – $119.46
52-Week Range
$84.42 – $127.77
Volume
4.67K
Avg Vol (50D)
46.37K
Beta
1.14

Historical Performance

1M
+0.73%
3M
+6.22%
6M
+19.03%
YTD
+23.46%
1Y
+36.48%
3Y
+54.18%
5Y
+45.80%

Total return including reinvested distributions, from adjusted closing prices.

Price History

Price history is being compiled for this fund.

Top Holdings

Invesco Private Prime Fund 24.33%
Invesco Private Government Fund 9.28%
Bel Fuse Inc. 1.88%
Terns Pharmaceuticals, Inc. 1.58%
Sezzle Inc. 1.54%
Planet Labs PBC 1.50%
Tutor Perini Corp. 1.49%
Lumentum Holdings Inc. 1.40%
Kodiak Sciences Inc. 1.37%
Celcuity Inc. 1.37%
Graham Corp. 1.32%
Nuvalent, Inc. 1.26%
Praxis Precision Medicines, Inc. 1.16%
Cogent Biosciences, Inc. 1.09%
Frequency Electronics, Inc. 1.08%
Amneal Pharmaceuticals, Inc. 1.07%
Idaho Strategic Resources, Inc. 1.01%
Alumis Inc. 0.99%
Enova International, Inc. 0.98%
TTM Technologies, Inc. 0.91%
VSE Corp. 0.90%
RAPT Therapeutics, Inc. 0.88%
Northeast Bank 0.84%
EchoStar Corp. 0.79%
Inhibrx Biosciences, Inc. 0.78%

Top 25 holdings as of Feb 28, 2026 · source: SEC N-PORT. Full holdings & prospectus →

About DWAS

The Fund generally will invest at least 90% of its total assets in the securities that comprise the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, Dorsey, Wright & Associates, LLC (“Dorsey Wright” or the “Index Provider”) compiles and maintains the Underlying Index, which is composed of approximately 200 securities from an eligible universe of approximately 2,000 small-cap securities (that is, securities ranked 1,001 to 3,000 by market capitalization within the Nasdaq US BenchmarkTM Index, a float adjusted market capitalization-weighted index designed to track the performance of the U.S. equity market). Dorsey Wright selects securities for the Underlying Index pursuant to a proprietary selection methodology that is designed to identify companies that demonstrate powerful relative strength or “momentum” characteristics. “Relative strength” is an investing technique that seeks to determine the strongest performing securities by measuring certain factors, such as a security’s relative performance against the overall market over a set period or a security’s relative strength value, which is derived by comparing the rate of increase of the security’s price as compared to that of a benchmark index. The Index Provider uses a proprietary methodology to analyze the relative strength of each security within the universe of eligible securities and determine a “momentum” score. In general, momentum is the tendency of an investment to exhibit persistence in its relative performance; a “momentum” style of investing emphasizes investing in securities that have had better recent performance compared to other securities. The momentum score for each security included in the Underlying Index is based on intermediate and long-term price movements of the security as compared to a representative benchmark and other eligible securities within the Underlying Index universe. After giving each eligible security a momentum score, the Index Provider selects approximately 200 securities with the highest momentum scores for inclusion in the Underlying Index. The Index Provider weights each security by its momentum score, with higher scoring securities representing a greater weight in the Underlying Index. As of October 31, 2024, the Underlying Index was comprised of 200 securities with market capitalizations ranging from $176.9 million to $31.8 billion. The Fund employs a “full replication” methodology in seeking to track the Underlying Index, meaning that the Fund generally invests in all of the securities comprising the Underlying Index in proportion to their weightings in the Underlying Index.The Fund intends to be “diversified,” as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), to the extent that the Underlying Index is diversified. The Fund may become “non-diversified” as defined in the 1940 Act solely as a result of a change in relative market capitalization or index weighting of one or more constituents of the Underlying Index. Should the Fund become “non-diversified,” it will no longer be required to meet certain diversification requirements under the 1940 Act and may invest a greater portion of its assets in securities of a small group of issuers or in any one individual issuer than can a diversified fund. Shareholder approval will not be sought when the Fund crosses from diversified to non-diversified status solely due to a change in relative market capitalization or index weighting of one or more constituents of the Underlying Index. In seeking to track the Underlying Index, the Fund was managed as diversified as of August 31, 2024. Concentration Policy. The Fund will concentrate its investments (i.e., invest more than 25% of the value of its net assets) in securities of issuers in any one industry or group of industries only to the extent that the Underlying Index reflects a concentration in that industry or group of industries. The Fund will not otherwise concentrate its investments in securities of issuers in any one industry or group of industries. As of August 31, 2024, the Fund had significant exposure to the industrials sector. The Fund's portfolio holdings, and the extent to which it concentrates its investments, are likely to change over time.

Data for DWAS is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.